XERODERMA PIGMENTOSUM

Clinical trials for XERODERMA PIGMENTOSUM explained in plain language.

Never miss a new study

Get alerted when new XERODERMA PIGMENTOSUM trials appear

Sign up with your email to follow new studies for XERODERMA PIGMENTOSUM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

Early trial for young cancer patients halted before starting

Disease control Terminated

This early-phase study aimed to test the safety and effectiveness of a two-drug immunotherapy combination (nivolumab and ipilimumab) in children, teens, and young adults. It was specifically for patients whose cancers had returned or stopped responding to standard treatments and …

Matched conditions: XERODERMA PIGMENTOSUM

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 01, 2026 14:40 UTC

XERODERMA PIGMENTOSUM

Get alerted when new XERODERMA PIGMENTOSUM trials appear

Early trial for young cancer patients halted before starting